Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec;34(12):e70187.
doi: 10.1111/exd.70187.

Genetic Variants and Polygenic Risk Scores Linked to Atopic Dermatitis Risk, Severity, and Serum IgE Levels

Affiliations

Genetic Variants and Polygenic Risk Scores Linked to Atopic Dermatitis Risk, Severity, and Serum IgE Levels

Chang-Ching Wei et al. Exp Dermatol. 2025 Dec.

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease with high heritability, yet its genetic basis, especially in non-European populations, is not fully elucidated. To identify genetic variants associated with AD and to evaluate polygenic risk scores (PRS) for predicting AD risk, severity, and serum IgE levels in a Taiwanese Han population. We conducted a genome-wide association study (GWAS) using data from the China Medical University Hospital Biobank (1031 AD cases, 2106 controls). Two PRS models were developed: PRS_AD (AD risk) and PRS_IgE (IgE levels). The cohort was split into discovery and replication sets (8:2 ratio). Logistic regression, adjusted for age, sex, and population stratification, was used. The GWAS identified a novel AD-associated locus: rs905307 in RANBP2 (OR = 0.66, p = 2.75 × 10-8). PRS_IgE was significantly associated with increased AD risk (OR = 2.230, 95% CI = 1.815-2.741, p < 0.001) and correlated with serum IgE levels (r = 0.168, p < 0.001). Patients requiring systemic treatment for severe AD had significantly higher PRS_IgE scores (p = 0.017). This study identified a novel genetic locus associated with AD and highlights a shared genetic basis between IgE levels and AD. PRS_IgE demonstrates potential for predicting AD risk and severity, suggesting opportunities for early intervention and personalized management in the Taiwanese Han population. Further research is needed to confirm these findings and explore clinical applications.

Keywords: RANBP2; GWAS; IgE; PRS; atopic dermatitis; genetic variants; precision medicine.

PubMed Disclaimer

References

    1. D. Y. Leung, “New Insights Into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation,” Allergology International 62, no. 2 (2013): 151–161, https://doi.org/10.2332/allergolint.13‐RAI‐0564.
    1. P. Y. Ong, “Atopic Dermatitis: Is Innate or Adaptive Immunity in Control? A Clinical Perspective,” Frontiers in Immunology 13 (2022): 943640, https://doi.org/10.3389/fimmu.2022.943640.
    1. N. Novak, S. Koch, J. P. Allam, and T. Bieber, “Dendritic Cells: Bridging Innate and Adaptive Immunity in Atopic Dermatitis,” Journal of Allergy and Clinical Immunology 125, no. 1 (2010): 50–59, https://doi.org/10.1016/j.jaci.2009.11.019.
    1. C. Elmose and S. F. Thomsen, “Twin Studies of Atopic Dermatitis: Interpretations and Applications in the Filaggrin Era,” Journal of Allergy (Cairo) 2015 (2015): 902359, https://doi.org/10.1155/2015/902359.
    1. L. Bin and D. Y. Leung, “Genetic and Epigenetic Studies of Atopic Dermatitis,” Allergy, Asthma & Clinical Immunology 12 (2016): 52, https://doi.org/10.1186/s13223‐016‐0158‐5.

Substances